139 related articles for article (PubMed ID: 38158989)
1. [Long-term use of glucocorticoids in patients with active rheumatoid arthritis: therapeutic "freeze frame"].
Gordeev AV; Matyanova EV; Galushko EA
Ter Arkh; 2023 Jul; 95(5):380-385. PubMed ID: 38158989
[TBL] [Abstract][Full Text] [Related]
2. [Difficult-to-treat rheumatoid arthritis in real clinical practice. Preliminary results].
Galushko EA; Gordeev AV; Matyanova EV; Olyunin YA; Nasonov EL
Ter Arkh; 2022 Jun; 94(5):661-666. PubMed ID: 36286966
[TBL] [Abstract][Full Text] [Related]
3. Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry.
Jung JY; Lee E; Kim JW; Suh CH; Shin K; Kim J; Kim HA
Arthritis Res Ther; 2023 Sep; 25(1):174. PubMed ID: 37726808
[TBL] [Abstract][Full Text] [Related]
4. Early characterization of difficult-to-treat rheumatoid arthritis by suboptimal initial management: a multicentre cohort study.
Giollo A; Zen M; Larosa M; Astorri D; Salvato M; Calligaro A; Botsios K; Bernardi C; Bianchi G; Doria A
Rheumatology (Oxford); 2023 Jun; 62(6):2083-2089. PubMed ID: 36190344
[TBL] [Abstract][Full Text] [Related]
5. Effect of Glucocorticoids on the Clinical and Radiographic Efficacy of Tofacitinib in Patients with Rheumatoid Arthritis: A Posthoc Analysis of Data from 6 Phase III Studies.
Charles-Schoeman C; van der Heijde D; Burmester GR; Nash P; Zerbini CAF; Connell CA; Fan H; Kwok K; Bananis E; Fleischmann R
J Rheumatol; 2018 Feb; 45(2):177-187. PubMed ID: 29142036
[TBL] [Abstract][Full Text] [Related]
6. Calcification of coronary arteries in early rheumatoid arthritis prior to anti-rheumatic therapy.
Udachkina HV; Novikova DS; Popkova TV; Kirillova IG; Markelova EI; Luchikhina EL; Lukina GV; Sinitsyn VE; Karateev DE; Nasonov EL
Rheumatol Int; 2018 Feb; 38(2):211-217. PubMed ID: 29079928
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of low-dose glucocorticoids combined with methotrexate and hydroxychloroquine in the treatment of early rheumatoid arthritis: A single-center, randomized, double-blind clinical trial.
Hua L; Du H; Ying M; Wu H; Fan J; Shi X
Medicine (Baltimore); 2020 Jul; 99(27):e20824. PubMed ID: 32629668
[TBL] [Abstract][Full Text] [Related]
8. Tapering and discontinuation of oral glucocorticoids without deterioration of disease status in patients with rheumatoid arthritis under a stable treatment.
Hirata S; Kohno H; Watanabe H; Tokunaga T; Yoshida Y; Sugimoto T; Mokuda S; Oda K; Nojima T; Sugiyama E
Mod Rheumatol; 2021 Jul; 31(4):803-808. PubMed ID: 33325280
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics and variants that predict prognosis of difficult-to-treat rheumatoid arthritis.
Yoshii I; Sawada N; Chijiwa T
Rheumatol Int; 2022 Nov; 42(11):1947-1954. PubMed ID: 35410410
[TBL] [Abstract][Full Text] [Related]
10. Dynamic of changes in coronary artery calcification in early rheumatoid arthritis patients over 18 months.
Udachkina HV; Novikova DS; Popkova TV; Kirillova IG; Markelova EI
Rheumatol Int; 2018 Jul; 38(7):1217-1224. PubMed ID: 29748857
[TBL] [Abstract][Full Text] [Related]
11. Real-world patient characteristics and use of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: a cross-national study.
Ingrasciotta Y; Jin Y; Foti SS; Landon JE; Tari M; Mattace-Raso F; Kim SC; Trifirò G
Clin Rheumatol; 2023 Apr; 42(4):1047-1059. PubMed ID: 36534353
[TBL] [Abstract][Full Text] [Related]
12. Prognostic markers of clinical remission in early rheumatoid arthritis after two years of DMARDs in a clinical setting.
Vázquez I; Graell E; Gratacós J; Cañete JD; Viñas O; Ercilla MG; Gómez A; Hernández MV; Rodríguez-Cros JR; Larrosa M; Sanmartí R
Clin Exp Rheumatol; 2007; 25(2):231-8. PubMed ID: 17543147
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid trajectories over 2 years in patients with rheumatoid arthritis in a real-life setting.
Delteil A; Lambert C; Pereira B; Couderc M; Malochet-Guinamand S; Pickering ME; Villedon M; Mathieu S; Soubrier M; Tournadre A
RMD Open; 2023 Oct; 9(4):. PubMed ID: 37880179
[TBL] [Abstract][Full Text] [Related]
14. Similar short-term clinical response to high-dose versus low-dose methotrexate in monotherapy and combination therapy in patients with rheumatoid arthritis.
Bergstra SA; Allaart CF; van den Berg R; Chopra A; Govind N; Huizinga TWJ; Landewe RBM
Arthritis Res Ther; 2017 Nov; 19(1):258. PubMed ID: 29166919
[TBL] [Abstract][Full Text] [Related]
15. Preferable outcome of Janus kinase inhibitors for a group of difficult-to-treat rheumatoid arthritis patients: from the FIRST Registry.
Ochi S; Sonomoto K; Nakayamada S; Tanaka Y
Arthritis Res Ther; 2022 Mar; 24(1):61. PubMed ID: 35232462
[TBL] [Abstract][Full Text] [Related]
16. Does addition of glucocorticoids to the initial therapy influence the later course of the disease in patients with early RA? Results from the Swiss prospective observational registry (SCQM).
Mueller RB; Reshiti N; Kaegi T; Finckh A; Haile SR; Schulze-Koops H; Schiff M; Spaeth M; von Kempis J;
Clin Rheumatol; 2017 Jan; 36(1):59-66. PubMed ID: 27838788
[TBL] [Abstract][Full Text] [Related]
17. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.
Smolen JS; Landewé R; Bijlsma J; Burmester G; Chatzidionysiou K; Dougados M; Nam J; Ramiro S; Voshaar M; van Vollenhoven R; Aletaha D; Aringer M; Boers M; Buckley CD; Buttgereit F; Bykerk V; Cardiel M; Combe B; Cutolo M; van Eijk-Hustings Y; Emery P; Finckh A; Gabay C; Gomez-Reino J; Gossec L; Gottenberg JE; Hazes JMW; Huizinga T; Jani M; Karateev D; Kouloumas M; Kvien T; Li Z; Mariette X; McInnes I; Mysler E; Nash P; Pavelka K; Poór G; Richez C; van Riel P; Rubbert-Roth A; Saag K; da Silva J; Stamm T; Takeuchi T; Westhovens R; de Wit M; van der Heijde D
Ann Rheum Dis; 2017 Jun; 76(6):960-977. PubMed ID: 28264816
[TBL] [Abstract][Full Text] [Related]
18. The new 2010 ACR/EULAR criteria as predictor of clinical and radiographic response in patients with early arthritis.
Mueller RB; Schiff M; Kaegi T; Finckh A; Haile SR; Schulze-Koops H; von Kempis J;
Clin Rheumatol; 2015 Jan; 34(1):51-9. PubMed ID: 25024096
[TBL] [Abstract][Full Text] [Related]
19. Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis.
Finckh A; Bansback N; Marra CA; Anis AH; Michaud K; Lubin S; White M; Sizto S; Liang MH
Ann Intern Med; 2009 Nov; 151(9):612-21. PubMed ID: 19884622
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and predictive factors of difficult-to-treat rheumatoid arthritis: the KURAMA cohort.
Watanabe R; Hashimoto M; Murata K; Murakami K; Tanaka M; Ohmura K; Ito H; Matsuda S
Immunol Med; 2022 Mar; 45(1):35-44. PubMed ID: 34033729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
